药品详细
Cefaclor(头孢克洛)
化学结构式图
中文名
头孢克洛
英文名
Cefaclor
分子式
C15H14ClN3O4S
化学名
(6R,7R)-7-[(2R)-2-amino-2-phenylacetamido]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
分子量
Average: 367.807
Monoisotopic: 367.039354348
Monoisotopic: 367.039354348
CAS号
53994-73-3
ATC分类
J01D Other Beta- lactam Antibacterials
药物类型
small molecule
阶段
approved
商品名
Alenfral;Alfacet;Alfatil;Ceclor;Ceclor CD;Distaclor;Kefral;Panacef;Panoral;Raniclor;
同义名
CCL;Cefaclor anhydrous;Cefaclorum [INN-Latin];Cephaclor;
基本介绍
Semisynthetic, broad-spectrum antibiotic derivative of cephalexin. [PubChem]
生产厂家
- Acs dobfar info sa
- Ceph international corp
- Clonmel healthcare ltd
- Eli lilly and co
- Hikma pharmaceuticals
- Ivax pharmaceuticals inc sub teva pharmaceuticals usa
- Marsam pharmaceuticals llc
- Ranbaxy laboratories ltd
- Ranbaxy pharmaceuticals inc
- Teva pharmaceuticals usa inc
- World gen llc
- Yung shin pharmaceutical industrial co ltd
封装厂家
- Advanced Pharmaceutical Services Inc.
- Aidarex Pharmacuticals LLC
- Alvogen Inc.
- Apothecon
- A-S Medication Solutions LLC
- Bryant Ranch Prepack
- C.O. Truxton Inc.
- Carlsbad Technology Inc.
- Corepharma LLC
- DAVA Pharmaceuticals
- Direct Dispensing Inc.
- Dispensing Solutions
- Diversified Healthcare Services Inc.
- Eli Lilly & Co.
- H.J. Harkins Co. Inc.
- Ivax Pharmaceuticals
- Jazeera Pharmaceutical Industries
- Lake Erie Medical and Surgical Supply
- Lilly Del Caribe Inc.
- Major Pharmaceuticals
- Novopharm Ltd.
- Nucare Pharmaceuticals Inc.
- Palmetto Pharmaceuticals Inc.
- Par Pharmaceuticals
- Patheon Inc.
- PD-Rx Pharmaceuticals Inc.
- PEDiNOL
- Pharma Pac LLC
- Pharmaceutical Utilization Management Program VA Inc.
- Pharmedix
- Physicians Total Care Inc.
- Preferred Pharmaceuticals Inc.
- Qualitest
- Ranbaxy Laboratories
- Rebel Distributors Corp.
- Redpharm Drug
- Southwood Pharmaceuticals
- Teva Pharmaceutical Industries Ltd.
- West-Ward Pharmaceuticals
- World Gen LLC
- Yung Shin Pharmaceutical Industry Ltd.
参考
Synthesis Reference | Not Available |
General Reference |
|
剂型
规格
化合物类型
Type | small molecule |
Classes | Not Available |
Substructures | Not Available |
适应症
antibacterials 抗细菌;
药理
Indication | For the treatment of certain infections caused by bacteria such as pneumonia and ear, lung, skin, throat, and urinary tract infections. |
Pharmacodynamics | Cefaclor is a second generation cephalosporin antibiotic with a spectrum resembling first-generation cephalosporins. In vitro tests demonstrate that the bactericidal action of the cephalosporins results from inhibition of cell-wall synthesis. Cefaclor has been shown to be active against most strains of the following microorganisms, both in vitro and in clinical infections: Gram positive aerobes - Staphylococci (including coagulase-positive, coagulase-negative, and penicillinase-producing strains), Streptococcus pneumoniae, and Streptococcus pyogenes (group A ß-hemolytic streptococci). Gram-negative aerobes - Escherichia coli, Haemophilus influenzae (including ß-lactamase-producing ampicillin-resistant strains), Klebsiella sp, and Proteus mirabilis. |
Mechanism of action | Cefaclor, like the penicillins, is a beta-lactam antibiotic. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins. It is possible that cefaclor interferes with an autolysin inhibitor. |
Absorption | Well absorbed after oral administration, independent of food intake. |
Volume of distribution | Not Available |
Protein binding | 23.5% |
Metabolism |
No appreciable biotransformation in liver (approximately 60% to 85% of the drug is excreted unchanged in the urine within 8 hours).
|
Route of elimination | Approximately 60% to 85% of the drug is excreted unchanged in the urine within 8 hours, the greater portion being excreted within the first 2 hours. |
Half life | 0.6-0.9 hour |
Clearance | Not Available |
Toxicity | Symptoms of overdose include diarrhea, nausea, stomach upset, and vomiting. |
Affected organisms |
|
Pathways | Not Available |
理化性质
Properties | |||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
State | solid | ||||||||||||||||||||||||||||||||||||||||||
Experimental Properties |
|
||||||||||||||||||||||||||||||||||||||||||
Predicted Properties |
|
药物相互作用
Drug | Interaction |
---|---|
Probenecid | Probenecid may increase the serum level of cefaclor. |
食物相互作用
- Preferably on an empty stomach, not really problematic.